Saracatinib Mitigates OP nerve agent-induced Long-term Neurotoxicity
Saracatinib 减轻 OP 神经毒剂引起的长期神经毒性
基本信息
- 批准号:9916826
- 负责人:
- 金额:$ 18.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAffectAftercareAlzheimer&aposs DiseaseAnimal ModelAnimalsAntiepileptogenicAtropineBehavioralBiological AssayBiological AvailabilityBrainBrain DiseasesBrain InjuriesCancer PatientCause of DeathCessation of lifeChemical AgentsChemical WarfareChemical Warfare AgentsCholinesterase InhibitorsClinical TrialsCognitiveDevicesDiazepamDiseaseDoseElectroencephalographyEnglandEpilepsyEpileptogenesisExposure toFemaleFosteringFunctional disorderGenesHealthHomicideHospitalsHourHumanImpaired cognitionImpairmentImplantKnockout MiceLifeLong-Term EffectsMalaysiaMalignant NeoplasmsMeasuresMicrogliaMidazolamMissionModelingMonitorMotorMotor SeizuresMusNADPH OxidaseNerve DegenerationNeurologicNeuronsNeuroprotective AgentsNitrogenOralOrganophosphatesOxidative StressOximesOxygenPharmaceutical PreparationsPhase II/III Clinical TrialPopulationPopulations at RiskProductionPublicationsRattusReportingResearch SupportRestRoleSarinSeizuresSerumSomanSprague-Dawley RatsStatus EpilepticusSurvivorsSymptomsSyriaTelemetryTerrorismTestingTherapeuticTokyoTyrosine Kinase InhibitorWireless Technologybehavior testblood-brain barrier permeabilizationbrain electrical activitycancer clinical trialcancer typechemical threatcholinergiccomorbidityconventional therapycytokineeffective therapyexperimental studyforced swim testglobal healthimprovedkainatemalemedical countermeasuremorris water mazemouse modelnerve agentneuroinflammationneuroprotectionneurotoxicitynovelnovel therapeutic interventionnovel therapeuticspreventprogramspsychologicresearch and developmentsrc-Family Kinasestoxic organophosphate insecticide exposuretranslational approach
项目摘要
Chemical warfare nerve agents (NA) are increasingly used to attack civilians worldwide. The past sarin attacks
in Tokyo, VX usage in homicide attack in Malaysia, the recent sarin attacks in Syria on civilians, and the most
recent Novichok ("newcomer") attack in England reiterate the real threat of chemical warfare NA to civilian
population. NA in the hands of terrorists pose threat to human health globally and currently we lack effective
treatment for survivors. Preventing acute death due to NA exposure had taken top priority until recently. The
reports on the life-long health consequences of sarin attacks survivors are beginning to emerge, which
compels the discovery of new drugs or new therapeutic approaches to mitigate the long-term effects of acute
NA exposure. Sarin exposed subjects, though hospitalized and treated with conventional therapy, in the long-
term they developed seizures and cognitive, motor, and psychological impairment. Like organophosphates
(OP), NA are cholinesterase inhibitors and potent seizurogenic. In animal models, acute NA or OP exposure
causes prolonged seizures and other cholinergic symptoms. The current medical countermeasure drugs
(atropine, oxime, and diazepam) do not prevent the long-term neurotoxicity and comorbidity, which are largely
due to persistent neuroinflammation and neurodegeneration. Our overarching hypothesis is that a
combination of a novel neuroprotectant, saracatinib (SAR, also known as AZD0305), and countermeasure
drugs can prevent NA-induced long-term neurotoxicity and restore brain function. We propose to investigate
the long-term neuroprotective effects of a novel Fyn/Src family tyrosine kinase inhibitor, SAR in diisopropyl
flurophosphate (DFP) and a NA soman rat models. SAR is in clinical trials for Alzheimer's disease and for
several types of cancer patients. Recently we demonstrated the role of Fyn/Src kinase in neuroinflammation,
neurodegeneration, and seizures onset in the rat and mouse models, and showed that SAR treatment dampened
neuroinflammation, protected neurons and prevented/modified epileptogenesis. Our current experiments also
revealed a similar mechanism of epileptogenesis, neurodegeneration, and behavioral dysfunction in the rat
DFP model. Since the SAR post-treatment prevented and/or significantly modified epileptogenesis, we predict
that SAR can mitigate DFP- and soman-induced long-term neurotoxicity. In specific aim 1 and 2, we will
investigate the neuroprotective effect and rescue of cognitive dysfunction by SAR in the rat DFP and soman
models. We will also perform a battery of behavioral tests and conduct key proinflammatory cytokines (multiplex
assay) and nitro-oxidative stress assays. In some animals we will implant a wireless telemetry device to monitor
brain electrical activity to confirm the impact of SAR on neuroprotection, anti-epileptogenicity, and behavioral
rescue. Our proposal addresses the mission of the CounterACT program ["to foster and support research and
development of new and improved therapeutics to mitigate the health effects of chemical threats"], and may
yield a novel therapy for NA-induced long-term neurotoxicity.
化学战神经毒剂(NA)越来越多地用于攻击世界各地的平民。过去的沙林毒气袭击
在东京,VX在马来西亚杀人袭击中的使用,最近在叙利亚对平民的沙林袭击,以及最严重的
最近在英国发生的Novichok(“新来者”)袭击再次表明了化学战对平民的真实的威胁
人口NA在恐怖分子手中对全球人类健康构成威胁,目前我们缺乏有效的
对幸存者的治疗。直到最近,预防NA暴露导致的急性死亡一直是最优先考虑的问题。的
关于沙林毒气袭击幸存者终身健康后果的报告开始出现,
迫使发现新的药物或新的治疗方法,以减轻急性
NA暴露。沙林暴露的受试者,虽然住院和接受传统治疗,在长期-
他们发展为癫痫和认知、运动和心理障碍。比如有机磷
(OP),NA是胆碱酯酶抑制剂和有效的神经毒性。在动物模型中,急性NA或OP暴露
会导致长时间的癫痫和其他胆碱能症状。当前医疗对策药物
(阿托品、肟和地西泮)不能预防长期神经毒性和合并症,
因为持续的神经炎症和神经退化我们的首要假设是,
新型神经保护剂,saracatinib(SAR,也称为AZD 0305)和对策的组合
药物可以防止NA诱导的长期神经毒性并恢复脑功能。我们建议调查
一种新型Fyn/Src家族酪氨酸激酶抑制剂SAR在二异丙基
氟磷酸盐(DFP)和NA梭曼大鼠模型。SAR正在进行阿尔茨海默病和
几种类型的癌症患者最近,我们证明了Fyn/Src激酶在神经炎症中的作用,
在大鼠和小鼠模型中,
神经炎症,保护神经元和预防/改变癫痫发生。我们目前的实验也
揭示了大鼠癫痫发生、神经变性和行为功能障碍的相似机制
DFP模型由于SAR治疗后预防和/或显著改变癫痫发生,我们预测
SAR可以减轻DFP和梭曼诱导的长期神经毒性。在具体目标1和2中,我们将
研究SAR对大鼠DFP和梭曼的神经保护作用和对认知功能障碍的挽救作用
模型我们还将进行一系列的行为测试,并进行关键的促炎细胞因子(多重
测定)和硝基氧化应激测定。在某些动物身上我们会植入无线遥测装置来监测
脑电活动,以确认SAR对神经保护、抗癫痫和行为的影响。
救援我们的建议涉及反ACT计划的使命[“促进和支持研究,
开发新的和改进的疗法,以减轻化学威胁对健康的影响”],并可
为NA诱导的长期神经毒性提供了一种新的治疗方法。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.
- DOI:10.3389/fncel.2021.772868
- 发表时间:2021
- 期刊:
- 影响因子:5.3
- 作者:Gage M;Putra M;Gomez-Estrada C;Golden M;Wachter L;Gard M;Thippeswamy T
- 通讯作者:Thippeswamy T
Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Disease Modifier in the Rat DFP Model: Sex Differences, Neurobehavior, Gliosis, Neurodegeneration, and Nitro-Oxidative Stress.
- DOI:10.3390/antiox11010061
- 发表时间:2021-12-28
- 期刊:
- 影响因子:0
- 作者:Gage M;Putra M;Wachter L;Dishman K;Gard M;Gomez-Estrada C;Thippeswamy T
- 通讯作者:Thippeswamy T
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thimmasettappa Thippeswamy其他文献
Thimmasettappa Thippeswamy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thimmasettappa Thippeswamy', 18)}}的其他基金
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
Saracatinib 和 1400W 抵消神经毒剂引起的长期神经毒性
- 批准号:
10462795 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Mitoapocynin, a novel NOX2 inhibitor, mitigates nerve agents induced longterm neurotoxicity
Mitoapocynin 是一种新型 NOX2 抑制剂,可减轻神经毒剂引起的长期神经毒性
- 批准号:
10427177 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity
Saracatinib 和 1400W 抵消神经毒剂引起的长期神经毒性
- 批准号:
10661615 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Saracatinib and 1400W Counteract Nerve Agents-induced Long-term Neurotoxicity
Saracatinib 和 1400W 抵消神经毒剂引起的长期神经毒性
- 批准号:
10272573 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
Mitoapocynin, a novel NOX2 inhibitor, mitigates nerve agents induced longterm neurotoxicity
Mitoapocynin 是一种新型 NOX2 抑制剂,可减轻神经毒剂引起的长期神经毒性
- 批准号:
10178817 - 财政年份:2021
- 资助金额:
$ 18.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 18.67万 - 项目类别:
Research Grant